{
    "2018-05-31": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Gilead & Galapagos Announce Positive Data on Filgotinib",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Galapagos",
                        "Positive Data",
                        "Filgotinib"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Thursdayâ€™s Vital Data: Micron Technology, Inc. (MU), Bank of America Corp (BAC) and AbbVie Inc. (ABBV)",
                "features": {
                    "keywords": [
                        "Micron Technology",
                        "Bank of America",
                        "AbbVie",
                        "Vital Data"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Pfizer's Arthritis Drug Gets FDA Nod for Ulcerative Colitis",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Arthritis Drug",
                        "FDA Nod",
                        "Ulcerative Colitis"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Traders Are Furious After Computer Botches Stock Sale",
                "features": {
                    "keywords": [
                        "Traders",
                        "Furious",
                        "Computer",
                        "Botches",
                        "Stock Sale"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-14",
                "original_text": "AbbVie to Present New Data from Several Investigational Studies of Venetoclax as Monotherapy or in Combination for the Management of a Number of Difficult-to-Treat Blood Cancers at 23rd European Hematology Association (EHA) Annual Congress",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Venetoclax",
                        "Investigational Studies",
                        "Blood Cancers",
                        "EHA Annual Congress"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}